Rare diseases
Investigational molecules
Locations
375 Rue Du Professeur Blayac, 34080 Montpellier, France
Sensorion focuses on cisplatin-induced hearing loss, with clinical research centered on protecting auditory function in adults exposed to ototoxicity associated with cancer treatment.
The sponsor’s research activity in this area reflects a therapeutic interest in preserving inner ear function in patients receiving cisplatin.
Sensorion runs clinical trials in conditions such as Deafness, Deafness bilateral, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
Safety, Tolerability and Efficacy of Intracochlear SENS-601 in Children with GJB2‑Related Hearing Loss
FranceStudy on SENS-401 to Prevent Hearing Loss Caused by Cisplatin in Adults with Cancer
FranceStudy on SENS-501 for Children with Severe Hearing Loss Due to Otoferlin Gene Mutations
FranceIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
